Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

被引:55
作者
Fan, YF
Lu, CC
Chang, YC
Chang, TT
Lin, PW
Lei, HY
Su, IJ
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan 70101, Taiwan
[4] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Dept Immunol & Microbiol, Tainan 70101, Taiwan
[6] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan
关键词
chronic hepatitis B virus infection; hepatocarcinogenesis; marginal hepatitis B surface antigen; pre-S2 deletion mutant;
D O I
10.1046/j.1440-1746.2000.02187.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: The expression of hepatitis B viral (HBV) antigens in liver tissue reflects the replicative status of chronic HBV infection. We have previously recognized a novel marginal pattern of hepatitis B surface antigen (HBsAg) in hepatocytes, which usually clusters in groups and emerges at the late non-replicative phase. This study was designed to investigate whether the marginal-type HBsAg represented the gene product of a specific HBV-surface mutant. Methods: Microdissection of cirrhotic nodules homogeneously expressing marginal HBsAg was performed on two of 12 resected livers from HBsAg-seropositive patients with hepatocellular carcinoma. The gene presumably encoding marginal HBsAg was polymerase chain reaction (PCR)-cloned, sequenced and analysed. In vitro transfection and expression of the cloned surface mutant plasmids were performed on the Huh7 cell line to illustrate intrahepatic HBsAg expression. Results: Immunohistochemical staining revealed that the marginal HBsAg was positive for pre-S1 and thus contained large surface proteins. The PCR cloning and sequencing of the genes presumably encoding marginal-type HBsAg in both cases revealed the same deletion at the 5' terminus (nt 2-55) of pre-S2. A point mutation on the small-surface (S) antigen was also found in one case. The pre-S2 deletion sequence and the mutation sites of the S gene coincide with human lymphocyte antigen-restricted T- and/or B-cell epitopes. In vitro transfection of the mutant plasmid revealed a blot-like retention or accumulation of HBsAg in the cytoplasm or at the periphery of hepatocytes, accompanied by a decreased secretion of HBsAg in the culture supernatant, mimicking intrahepatic expression. Conclusion: A natural pre-S2 deletion mutant was identified in hepatocytes expressing a novel marginal pattern of HBsAg, which probably contains mutant, large, surface proteins. The biological significance of the pre-S2 deletion mutant should be interesting in view of the clustering proliferation of hepatocytes expressing marginal HBsAg. (C) 2000 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 50 条
[1]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO A WILD-TYPE HEPATITIS-B VIRUS EPITOPE IN PATIENTS CHRONICALLY INFECTED BY VARIANT VIRUSES CARRYING SUBSTITUTIONS WITHIN THE EPITOPE [J].
BERTOLETTI, A ;
COSTANZO, A ;
CHISARI, FV ;
LEVRERO, M ;
ARTINI, M ;
SETTE, A ;
PENNA, A ;
GIUBERTI, T ;
FIACCADORI, F ;
FERRARI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :933-943
[2]   NATURAL VARIANTS OF CYTOTOXIC EPITOPES ARE T-CELL RECEPTOR ANTAGONISTS FOR ANTIVIRAL CYTOTOXIC T-CELLS [J].
BERTOLETTI, A ;
SETTE, A ;
CHISARI, FV ;
PENNA, A ;
LEVRERO, M ;
DECARLI, M ;
FIACCADORI, F ;
FERRARI, C .
NATURE, 1994, 369 (6479) :407-410
[3]   VIRAL GENETIC-VARIATION - HEPATITIS-B VIRUS AS A CLINICAL EXAMPLE [J].
CARMAN, W ;
THOMAS, H ;
DOMINGO, E .
LANCET, 1993, 341 (8841) :349-353
[4]   Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus [J].
Chang, KM ;
Rehermann, B ;
McHutchison, JG ;
Pasquinelli, C ;
Southwood, S ;
Sette, A ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2376-2385
[5]  
CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2
[6]   MOLECULAR PATHOGENESIS OF HEPATOCELLULAR-CARCINOMA IN HEPATITIS-B VIRUS TRANSGENIC MICE [J].
CHISARI, FV ;
KLOPCHIN, K ;
MORIYAMA, T ;
PASQUINELLI, C ;
DUNSFORD, HA ;
SELL, S ;
PINKERT, CA ;
BRINSTER, RL ;
PALMITER, RD .
CELL, 1989, 59 (06) :1145-1156
[7]   STRUCTURAL AND PATHOLOGICAL EFFECTS OF SYNTHESIS OF HEPATITIS-B VIRUS LARGE ENVELOPE POLYPEPTIDE IN TRANSGENIC MICE [J].
CHISARI, FV ;
FILIPPI, P ;
BURAS, J ;
MCLACHLAN, A ;
POPPER, H ;
PINKERT, CA ;
PALMITER, RD ;
BRINSTER, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6909-6913
[8]   HEPATITIS-B VIRUS IMMUNOPATHOGENESIS [J].
CHISARI, FV ;
FERRARI, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :29-60
[9]   EXPRESSION OF HEPATITIS-B VIRUS LARGE ENVELOPE POLYPEPTIDE INHIBITS HEPATITIS-B SURFACE-ANTIGEN SECRETION IN TRANSGENIC MICE [J].
CHISARI, FV ;
FILIPPI, P ;
MCLACHLAN, A ;
MILICH, DR ;
RIGGS, M ;
LEE, S ;
PALMITER, RD ;
PINKERT, CA ;
BRINSTER, RL .
JOURNAL OF VIROLOGY, 1986, 60 (03) :880-887
[10]   Cytotoxic T cells and viral hepatitis [J].
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1472-1477